|
Effective August 1, 2016, Apidra and Apidra SoloSTAR — insulins used to treat type 1 diabetes in children and adults, and type 2 diabetes in adults only — will move from Tier 2 to Tier 3 on the 3-Tier Premium Formulary, and from Tier 3 to Tier 4 on the 4-Tier Premium Formulary. The comparable insulin product Humalog is available at Tier 2 on the 3-Tier Premium Formulary and Tier 3 on the 4-Tier Premium Formulary. Members were notified of the tier change for Apidra and Apidra SoloSTAR in early June.
|
